热门资讯> 正文
Belite Bio宣布注册直接发行1500万美元
2025-08-07 21:23
- Belite Bio (NASDAQ:BLTE) on Thursday said it has entered into a securities purchase agreement for the purchase and sale of 230,770 American Depositary Shares and warrants to purchase 230,770 ADSs, at a purchase price of $65 per ADS and accompanying warrant, in a registered direct offering.
- The offering is expected to result in gross proceeds of approximately $15 million.
- The closing of the offering is expected to occur on or about August 8.
- The company intends to use the net proceeds from the offering for working capital and general corporate purposes.
- BLTE +1% premarket to $68.67.
- Source: Press Release
More on Belite Bio
- Belite Bio: Investors Face Tricky Decision Ahead Of Key STGD1 Study Readout
- Belite Bio signals positive DSMB review and targets 500-patient PHOENIX trial enrollment completion in Q3 2025 while maintaining strong cash runway
- Seeking Alpha’s Quant Rating on Belite Bio
推荐文章
一图看懂 | 亏损大幅收窄！小鹏Q2净亏损4.8亿元，去年同期12.8亿元；汽车交付量创历史新高
美股机会日报 | 重磅！特朗普正接受福克斯采访；获软银注资20亿美元，英特尔盘前涨超5%
一图看懂 | 创历史新高！小米Q2营收1159.56亿元，同比增长30.5%，超市场预期
一图看懂 | 泡泡玛特中期股东溢利增长近4倍！5大IP收入破10亿，“LABUBU”系列营收占比34.7%
家得宝将公布第二季度财报，华尔街关注其美国销售额能否实现连续三季度增长
东方甄选早盘涨超12% 7月初至今累计涨幅已超300%
硬刚特朗普？高盛再发悲观预测：美国就业市场恐进一步恶化！
超级牛市？南下资金踢爆港股，这类基金迎来投资机遇
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
